Add to a list

Inactive Instrument

Encision Inc. Stock Other OTC

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

OTC Markets Traded

Encision Inc. is a medical device company. It designs, develops, manufactures and markets patented surgical instruments that provide safety to patients undergoing minimally invasive surgery. Its segments include Product and Service. The Product segment designs, develops, manufactures and markets patented surgical instruments. The Service segment performs electrical engineering activities for external entities. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause tissue injury that may result in death. The AEM system consists of shielded 5mm AEM Instruments and an AEM monitor. Laparoscopic instruments have the integrated AEM design and include the full range of instruments that are common in laparoscopic surgery. The AEM monitor is compatible with electrosurgical generators.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	2.19M 1.9M 1.77M 1.63M 3.06M 209M 3.11M 20.8M 8.16M 105M 8.24M 8.06M 346M	P/E 2024	-12.5x	P/E 2025	-23.9x
Enterprise Value	3.25M 2.81M 2.63M 2.41M 4.53M 309M 4.6M 30.81M 12.09M 155M 12.21M 11.94M 513M	EV / Sales 2024	1.54x	EV / Sales 2025	1.03x
Free-Float	38.12%	Yield 2024 *	-	Yield 2025	-

Dec. 12	Encision Inc. Announces Management Changes	CI
Dec. 12	Encision Inc. Announces CEO Changes	CI
Nov. 13	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
Nov. 03	Encision Inc. Announces Resignation of Patrick Pace from Its Board of Directors, Effective October 30, 2025	CI
25-08-18	Encision Inc. announced that it has received $0.5 million in funding	CI
25-08-15	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-07-10	Encision Inc. Reports Earnings Results for the Full Year Ended March 31, 2025	CI
25-02-14	Encision Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
24-11-15	Earnings Flash (ECIA) ENCISION Reports Fiscal Q2 Revenue $1.8M	MT
24-11-14	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
24-08-14	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
24-07-15	Earnings Flash (ECIA) ENCISION Reports Q4 Revenue $1.5M	MT
24-07-15	Encision Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

Jul. 16	Encision : Announces Start of Stock Trading	PU
Jul. 14	Encision Inc. Announces Start of Stock Trading	AQ
May. 04	Encision Inc. Announces Halt of Stock Trading	AQ
Apr. 13	Encision Inc. Announces Fiscal 2026 Fourth Quarter and Full Year Results	AQ
Jan. 29	Encision : Announces Decision to Deregister its Common Stock	PU

Manager	Title	Age	Since
Robert Fries CEO	Chief Executive Officer	77	2025-12-07
Brandon Shepard DFI	Director of Finance/CFO	42	2024-07-31
Denise Baker LAW	General Counsel	-	2018-12-31

Director	Title	Age	Since
Vern Kornelsen BRD	Director/Board Member	93	1990-12-31
Robert Fries BRD	Director/Board Member	77	2024-04-16

Encision Inc. Stock Other OTC

Stocks

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

Valuation: Encision Inc.

Latest news : Encision Inc.

Press Releases: Encision Inc.

Quotes and Performance

Managers and Directors: Encision Inc.

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ENCISION INC.	-5.88%	-7.25%	-	-	849K
ABBOTT LABORATORIES	-0.14%	+2.00%	-19.71%	+2.38%	187B
MEDTRONIC PLC	+1.44%	+2.07%	-6.16%	+5.09%	112B
CENCORA, INC.	-1.40%	+2.93%	+12.39%	+72.56%	61.15B
HOYA CORPORATION	+2.38%	+3.92%	+32.78%	+60.21%	54.39B
BECTON, DICKINSON AND COMPANY	-0.12%	+6.79%	-8.60%	-37.18%	48.17B
DEXCOM, INC.	+2.08%	+1.56%	+7.47%	-23.62%	31.98B
MEDLINE INC.	+2.09%	-10.31%	-	-	30.91B
WEST PHARMACEUTICAL SERVICES, INC.	+1.57%	+3.85%	+46.93%	-11.52%	24.92B
STERIS PLC	+2.45%	+3.97%	-2.22%	+4.63%	23.15B
Average	+0.45%	+1.86%	+7.86%	+9.07%	63.64B
Weighted average by Cap.	+0.70%	+2.17%	-1.63%	+11.07%

	2024	2025
Net sales	6.59M 5.7M 5.32M 4.88M 9.18M 627M 9.32M 62.42M 24.5M 314M 24.73M 24.19M 1.04B	6.56M 5.67M 5.3M 4.86M 9.14M 624M 9.28M 62.13M 24.38M 313M 24.62M 24.08M 1.03B
Net income	-692K -598K -559K -513K -964K -65.84M -979K -6.56M -2.57M -33M -2.6M -2.54M -109M	-220K -190K -178K -163K -307K -20.96M -312K -2.09M -819K -10.5M -827K -809K -34.73M
Net Debt	1.29M 1.12M 1.04M 956K 1.8M 123M 1.83M 12.23M 4.8M 61.57M 4.85M 4.74M 204M	1.06M 914K 854K 783K 1.47M 101M 1.5M 10.02M 3.93M 50.41M 3.97M 3.88M 167M